← FDA Drug Approvals (Drugs@FDA)
NEOSTIGMINE METHYLSULFATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: DR REDDYS · Approved 2022-07-06
Drug application
- FDA Application #
ANDA216291- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NEOSTIGMINE METHYLSULFATE
- Generic name
- NEOSTIGMINE METHYLSULFATE
- Active ingredients
- NEOSTIGMINE METHYLSULFATE
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- DR REDDYS
- Manufacturer
- Dr.Reddys Laboratories Inc
- First approval
- 2022-07-06
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown